MEMBERSHIPS
◉ All India Ophthalmic Society(AIOS).
◉ Vitreo-Retinal Society of India(VRSI)
◉ Uttar Pradesh Ophthalmic Society(UPSOS).
◉ Delhi Ophthalmic Society(DOS)
◉ Women Ophthalmologists Society (WOS)
◉ Noida Ophthalmic Society(NOS)

 

Conferences Attended
◉ 1st Annual scientific meet of Kanpur Ophthalmic Society, Kanpur (U.P.)
◉ 44th Annual Conference of UP State Ophthalmic Society, Gorakhpur (U.P.)
◉ 61st Annual Conference of DOS, New Delhi.
◉ 20th Annual conference of GSI in Delhi in 2010.
◉ 45th Annual Conference of UP State Ophthalmic Society, Lucknow (U.P.).
◉ 62nd Annual Conference of DOS, New Delhi.
◉ 5th Mid Term State Ophthalmic Society Conference, Pilibhit (UKD)
◉ 22nd Annual Conference of Oculoplastics association of India, Kanpur (U.P.)
◉ 46th Annual Conference of UP State Ophthalmic Society, Lucknow (U.P.)
◉ Oculoplasty CME in Dr Shroff Charity Eye Hospital, 2012
◉ AIOS-APAO conference 2013, Hyderabad
◉ 63rd Annual Conference of DOS, New Delhi
◉ Mid-term conference DOS 2013, New Delhi
◉ AIOS annual conference 2015, New Delhi
◉ UPSOS Annual conference 2015, Allahabad
◉ DOS annual conference 2016, New Delhi
◉ Winter DOS 2016, New Delhi
◉ UPSOS Annual conference 2016, Gorakhpur
◉ WOS 2017, Jaipur
◉ AIOS 2018, Coimbatore
◉ WOS 2018, Hyderabad
◉ UPSOS 2019
◉ AIOC 2019
◉ WOS 2022
◉ UPSOS 2022

 

Courses Attended
◉ Workshop on Research Methodology & Publication by IJO & GSVM medical college in
Kanpur(U.P.)
◉ 1st AIOC Post Graduate refresher course in Ophthalmology in PGI, Chandigarh (Punjab)
◉ Post Graduate Education Program in Ophthalmology in LVPEI, Hyderabad (A.P.)
◉ Surgical implant course of Ahmed glaucoma value implant course, Kanpur (U.P.)
◉ Observership in Retina foundation in 2017

 

Presentations

1) Effect of Phacoemulsification and PCIOL implantation in cataract patients with or
without glaucoma- A Clinical Trial, Poster presentation in XXth Annual conference of GSI
in Delhi in 2010.
2) Effect of Phacoemulsification with PCIOL implantation in cataract patients with or
without glaucoma- A Clinical Trial, Poster presentation in 45th Annual conference of U.P.
State Ophthalmological Society.
3) A study on effect of phacoemulsification on IOP in cataract patients with or without
glaucoma in 46th Annual conference of U.P. State Ophthalmological Society.
4) Importance of systemic evaluation in ocular pathologies: a case report in 46th
Annual conference of U.P. State Ophthalmological Society.
5) Phacoemulsification in glaucoma: an alternative to medications in 46th Annual
conference of U.P. State Ophthalmological Society.
6) Effect of phacoemulsification in patients with occludable angles: a prospective case
series in 46th Annual conference of U.P. State Ophthalmological Society.
7) Phacoemulsification in glaucoma: an alternative to medications as an e-poster
presented in AIOS 2013.
8) Effect of phacoemulsification in patients with occludable angles: a prospective case
series as an e-poster presented in AIOS 2013.
9) Phacoemulsification with opposite clear corneal incision (OCCI) for treatment of
preexisting astigmatism in poor patients: A modality, as co-author in an e-poster
presented in AIOS 2013.
10) IC on Endoph in UPSOS 2015
11) IC on DME in UPSOS 2015
12) New Retina Protective Micropulse Laser for Macular Edema in Retinal Venous
Occlusions: a case series as an paper in V N Raizada Award Session UPSOS 2015
13) New Retina Protective Micropulse Laser for Macular Edema in Retinal Venous
Occlusions: A case series as an e-poster in DOSCON 2016
14) Fundus Finding in Diabetic Retinopathy in ARC-AIOS- North Zone, 2016
15) Ocular and Economic impact of digital exposure as physical poster in WinterDOS
2016
16) Ocular and Economic impact of digital exposure as paper in UPSOS 2016
17) Retinal Imaging Techniques as a tool for predicting visual prognosis in Diabetic
Retinopathy in UPSOS 2016
18) New OCT Parameter as a tool for predicting visual prognosis in Diabetic Retinopathy
in UPSOS 2016
19) Ocular and Economic impact of digital exposure as paper in AIOS 2018
20) Retinal Imaging Techniques as a tool for predicting visual prognosis in Diabetic
Retinopathy in AIOS 2018
21) Outer retinal Tubulations:A mimicker of Diabetic Macular Edema in UPSOS 2018.
22) Changing trends in Endophthalmitis: Report from a tertiary care eye centre in
UPSOS 2018
23) Innovative Wide- field OCT: Magic of Optics in UPSOS 2018
24) To assess the average change in refraction and IOL power adjustment after belt
buckle in UPSOS 2018
25) IC: Topic:-Endophthalmitis changing trends in demographics and management in
UPSOS 2018
26) ) Post traumatic Endophthalmitis: Is the trend changing? as poster podium
presentation in AIOC 2019
27) Clinical profile of multi-drug resistant gram negative bacterial endophthalmitis and
evaluation of outcomes after management with higher antibiotics in VRSI 2018 as eposter
28) Suprachoroidal injection – a novel, simple, safe and effective mode of drug delivery
for various posterior segment disorders in VRSI 2019
29) ROP screening: Challenges as paper in Retinal Giants Session in WOS 2022

 

Awards

◉ 2nd prize in in UPSOS in 2011 for poster on Effect of Phacoemulsification with
PCIOL implantation in cataract patients with or without glaucoma- A Clinical
Trial.
◉ Dr P K Pandey Award in UPSOS 2016 for presentation on Ocular and Economic
impact of digital exposure.
◉ Dr V N Raizada Gold Medal Award in UPSOS 2016 for presentation on New OCT
Parameter as a tool for predicting visual prognosis in Diabetic Retinopathy.

 

Published paper

◉ Khan P, Awasthi U, Khan L, Khan A, Siddique Z, Chand R. Pentoxiphylline: A therapeutic
remedy for optic neuropathies. Journal of evolution of Medical and Dental Sciences
2013;2(20):3516-22.
◉ Awasthi U, Grover R, Varshney A, Videkar C. Predictive Factors of Response to
Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous Chorioretinopathy.
Am J Ophthalmol. 2019 Jul;203:121.
◉ Awasthi U, Grover R, Videkar C, Varshney A. Comment on “Vitrectomy with scleral
buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal
detachment with PVR and inferior breaks”. Eye (Lond). 2019 May;33(5):852-853.
◉ Awasthi U, Videkar C. Re: Staurenghi et al.: Efficacy and safety of ranibizumab 0.5 mg for
the treatment of macular edema resulting from uncommon causes: twelve-month findings
from PROMETHEUS (Ophthalmology. 2018;125:850-862). Ophthalmology. 2019
Jun;126(6):e43.
◉ Awasthi U, Grover R, Videkar C, Varshney A. Correspondence. Retina. 2019
Dec;39(12):e53.
◉ Awasthi U, Grover R, Videkar C, Varshney A. Comment on: The role of posterior vitreous
detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection
for treatment of neovascular age-related macular degeneration. Indian J Ophthalmol. 2019
Oct;67(10):1783.
◉ Awasthi U, Mohan S. Immunological Basis of Symptomatology in Ocular Diseases. DJO
2018;28:9-13
◉ Awasthi U. Impact of Prolonged Digital Screens Exposure On Ocular Surface. DJO
2020;31:26-30.